ABSTRACT
CHAPTER TWO

INTRODUCTION
The process of viral and host co-evolvement has selected for antiviral CD8 + T-cell responses that are successful in ensuring survival of the host. As an apparent consequence, human circulating virus-specific CD8 + T-cells display distinct phenotypic and functional properties according to the virus or viral proteins they target [1] [2] [3] . Acute viruses, such as respiratory syncytial virus (RSV), influenza A virus (influenza), but also some persisting viruses, such as polyomavirus BK, induce CD8 + T-cells that predominantly display a CD45RA¯CCR7 + CD28 + CD27 + (central-memory) or CD45RA¯CCR7¯CD28 + CD27 + (early-differentiated) phenotype 1, [4] [5] [6] [7] [8] [9] [10] . These, and the CD45RA¯CCR7¯CD28 + CD27¯
(early-like) subset highly express CD127 (IL-7Rα), proliferate vigorously upon stimulation with cognate antigen and produce several cytokines, among which IL-2 11-13 . In contrast,
Epstein-Barr virus (EBV) and human cytomegalovirus (hCMV) can induce CD8 + T-cells with a CD45RA¯CCR7¯CD28¯CD27 + (intermediately-differentiated), CD45RA¯CCR7¯CD28¯CD27¯
(RA¯ effector-type) or CD45RA + CCR7¯CD28¯CD27¯ (RA + effector-type) phenotype 1, 3, 5, 14 .
These subsets less often express IL-7Rα, have stringent proliferation requirements, frequently express granzyme B and execute immediate cytotoxicity 11, 13, 15 .
In contrast to naïve cells, antigen-primed T-cells rapidly mount protective responses owing to their superior ability to produce molecules that are crucial for the immunological defense. Although the associations between the expression of CD45RA, CCR7, CD27, CD28
and function are well established 1, 4, 11, 12 , the actual expression of genes and the proteins that ultimately determine T-cell functionality is regulated by transcription factors (TFs).
For example, RORγt, FOXP3 and GATA3 drive the generation of type 17, regulatory and type 2 T-cells, respectively, whereas T-bet and eomesodermin (Eomes) are responsible for governing a type 1 cytotoxic differentiation program [16] [17] [18] [19] . Despite the substantial overlap in DNA-binding sequences and similarity in functions of T-bet and Eomes, such as inducing the expression of IFN-γ, granzyme B and IL-2Rβ, the acute phase CD8 + effector T-cell response in mice is impaired particularly in the absence of T-bet [16] [17] [18] [20] [21] [22] [23] , whereas Eomes is important for the formation of memory cells and secondary responses in the setting of reinfection 24 . Thus, T-bet and Eomes control distinct differentiation programs and different protective functions in CD8 + T-cells.
This raises the question whether T-bet and Eomes expression can be used to distinguish human virus-specific CD8 + T-cells with distinct functional programs. We, and others have recently shown that T-bet and Eomes expression varies in human CD8 + T-cell subsets and virus-specific populations 6,25-28 . Furthermore, their expression levels were also shown to distinctly correspond to the expression of IL-7Rα, granzymes and various co-inhibitory receptors expressed by exhausted CD8 + T-cells 26, 27, 29 . Here, we show that the T-bet and
Eomes expression state of an individual CD8 + T-cell corresponds to specific functional traits in a manner that is irrespective of the differentiation status defined by the CD45RA/CCR7/ CD28/CD27 subdivision. Importantly, the associations between surface phenotype, T-bet/ Eomes expression levels and the expression of IL-7Rα, granzyme K, Killer cell Lectin-like Receptor G1 (KLRG1) and granzyme B were found to vary strongly according to infection history, particularly against the background of HIV-1 infection, and to lesser extent of EBV and/or hCMV infection. Therefore, the level of T-bet/Eomes expression forms an essential second dimension in comprehending the specific differentiation state of individual human CD8 + T-cells.
RESULTS T-bet and Eomes expression levels vary independently during CD8 + T-cell differentiation
First we determined the distribution of the CD45RA/CCR7/CD28/CD27 phenotypes among CD8 + T-cells circulating in the peripheral blood compartment of healthy donors. Here the putatively naïve-, early-differentiated and RA + effector-type form the most substantial subsets ( Figure 1A ). As expected, HIV-1-infection strongly influences the characteristics of the CD8 + T-cell compartment 30 , in that the naïve population was smaller in size, whereas the intermediately-differentiated and the RA¯/ + effector-type populations were much larger ( Figure 1A ). This was also true when comparing absolute numbers of putatively naïve CD8 We then investigated how T-bet and Eomes are expressed by the CD45RA/CCR7/ CD28/CD27-defined subsets. As expected, in both healthy and HIV-1-infected subjects, each surface marker-defined subset was found to contain multiple T-bet/Eomes expression states 25 , however to varying extent and in healthy individuals seemingly in a restricted range. The putatively naïve-and central-memory populations mainly contained T-bet lo Eomes lo cells, with only minor or small representations of the other expression states. The heterogeneity increased among the early-differentiated, the early-like and the intermediately-differentiated subsets, whereas the distribution became skewed towards T-bet int-hi Eomes lo-hi states among the RA¯/ + effector-type subsets ( Figure 1C/S1C ).
Remarkably, in the HIV-1-infected individuals the CD45RA/CCR7/CD28/CD27-defined subsets expressed T-bet and/or Eomes at higher frequencies, nearly irrespective of the CD45RA/CCR7/CD28/CD27 phenotype ( Figure 1C/S1C ). Reciprocally, each of the six T-bet/Eomes populations in the total CD8 + T-cell pool comprised its own restricted range of surface marker-defined T-cell subsets, a distribution that was again different when comparing HIV-1-infected to healthy individuals ( Figure 1D /S1D).
In conclusion, the different CD45RA/CCR7/CD28/CD27-defined CD8 + T-cell subsets are each associated with a specific range of T-bet/Eomes expression patterns in healthy individuals. However, HIV-1-infection changes these relations profoundly.
Virus-specific memory populations display distinct T-bet/Eomes expression levels
Similar analyses were done for circulating virus-specific CD8 + memory T-cell populations.
As expected, RSV nuclear protein (NP)-, influenza matrix protein 1 (MP1)-and EBV nuclear protein 3a (EBNA-3a, a latent cycle protein)-specific cells were phenotypically mainly central-memory, early-differentiated and early-like cells ( A. The distribution of all possible CD45RA/CCR7/CD28/CD27 phenotypes among the total CD8+ T-cell pools of 20 healthy (upper panel) or 13 HIV-1-infected individuals (lower panel) B. and in the same groups, the distribution of the T-bet/Eomes expression states over the total CD8 + T-cell pools, mean/ SD shown C. T-bet/Eomes expression states per surface marker-defined subset D. and, reciprocally, of the surface marker-defined subsets per T-bet/Eomes population, where 'T' (denoting T-bet) and 'E' (denoting Eomes) are followed by either lo, int or hi, indicating a low, intermediate or high level of expression of the TFs, respectively (mean percentages shown, see Figure S1b -c for statistical dispersion). (e) Absolute numbers of overall (left panel) and naïve (right panel) CD8 + T-cells in healthy and HIV-1-infected individuals. Ns= not significant, * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
In conclusion, virus-specific populations display distinct T-bet/Eomes expression patterns ( Figure 2D ). However, even when being similar in surface phenotype, virusspecific CD8 + T-cell populations can differ substantially with regard to their T-bet and
Eomes expression, and vice versa. A.
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C. HIV+ Healthy T -b e t fo ld c h a n g e E o m e s fo ld c h a n g e T -b e t fo ld c h a n g e E o m e s fo ld c h a n g e Figure 3A) . On the other hand, granzyme B was expressed in the HIV-1-infected subjects earlier than the surface phenotype initially suggested, and was already found in substantial amounts in early-differentiated and early-like cells ( Figure 3A) .
We next identified associations between the expression of these functional markers and that of T-bet and/or Eomes. IL-7Rα was expressed most often by cells in a T-bet lo Eomes lo state, and declined progressively as the expression of T-bet and/or Eomes increases. Interestingly, for cells in HIV-1-infected individuals, the IL-7Rα-expression rates dropped faster ( Figure 3B ). Also, granzyme K was expressed particularly by cells in the T-bet lo/int Eomes hi expression states, and infrequently by cells not expressing Eomes, or by cells highly expressing T-bet ( Figure 3B ). Furthermore, KLRG1 and granzyme B, were found to be expressed in higher amounts by T-bet lo-int Eomes lo-hi cells in HIV-1-infected individuals than in healthy subjects ( Figure 3B ).
When examining virus-specific populations, the RSV-and influenza-specific CD8 + T-cells displayed the highest expression of IL-7Rα. This was lower for EBV-and hCMVspecific cells, until it was nearly absent from the HIV-1-specific cells ( Figure 3C ). Granzyme K was expressed most often by both EBV-specific populations and much less frequently by the other virus-specific populations ( Figure 3C ). KLRG1 and granzyme B were mainly expressed by EBV BMLF-1-, and in particular by hCMV-and HIV-1-specific populations ( Figure 3C ). Interestingly, hCMV pp65-specific cells circulating in HIV-1-infected individuals expressed significantly less IL-7Rα and granzyme K, while more often expressing granzyme B than the same population in healthy subjects ( Figure 3C ).
In conclusion, the expression levels of T-bet and Eomes predict for differences in the functional potential of CD8 + T-cell populations. Markedly, the associations between the T-bet/Eomes levels, the CD45RA/CCR7/CD28/CD28 phenotypes and the expressions Combining the CD45RA/CCR7/CD28/CD27 dimension and the T-bet/Eomes dimension more accurately predicts CD8 + T-cell functional potential Therefore, the combined analysis of the CD45RA/CCR7/CD28/CD27 phenotype-and the TF-dimension reveal a more accurate image of the functional potential of an individual CD8 + T-cell. Importantly, all these associations, and thus the make-up of the total CD8 + T-cell pool change significantly against the background of untreated HIV-1 infection, in particular when it concerns the overall expression of IL-7Rα and granzyme B.
Infection history influences the associations between surface phenotype, T-bet/Eomes expression levels and the functional potential
These findings urged us to determine whether EBV and/or hCMV infection also influenced the associations between surface phenotype, T-bet/Eomes expression and the expression of molecules predictive for T-cell function. However, we first examined cord blood samples, which mainly comprised naïve CD8 + T-cells and a modest amount of central-memory cells.
Remarkably, these samples also comprised intermediately-differentiated and RA + effectortype cells, although in very low numbers. The early-like and RAˉ effector-type subsets were not detected ( Figure 5A /S5A). Furthermore, the associations between surface phenotype, T-bet/Eomes expression levels and expression of molecules predictive for function were completely different from those in adult CD8 + T-cells. In contrast, whereas healthy adults with histories. These differences mainly concerned the expression of granzyme K and KLRG1 by the CD45RA/CCR7/CD28/CD27/T-bet/Eomes-defined CD8 + T-cell populations. Granzyme K was more often expressed by EBV single-and EBV/HCMV dual-infected individuals and KLRG1 levels were generally higher on the three dimensionally-defined CD8 + T-cell populations from EBV/hCMV dual-infected individuals ( Figure S9 ).
It must be noted that the hCMV/EBV double-negative individuals were younger than the hCMV/EBV double-and HIV-1 seropositive individuals and that the more pronounced differences noted specifically between these groups may also be due to age and pathogen exposure (Table II) , all factors that are known to influence the CD8 + T-cell differentiation state 2,3,14 .
In conclusion, although not as dramatic as HIV-1 infection, EBV and/or hCMV infection also influences the associations between the surface phenotype, the T-bet/Eomes expression level and the expression of molecules predictive for T-cell function in otherwise healthy adults. 
T-bet and Eomes expression states of virus-specific memory populations are imprinted early during primary infection in vivo
We then wanted to investigate how T-bet and Eomes are expressed by different virusspecific memory populations over the course of primary infection. Therefore, we determined the expression of the TFs by developing hCMV pp65-, EBV EBNA and EBV BZLF-1-specific CD8 + T-cell populations in longitudinally obtained samples deriving from two kidney transplant recipients who each nearly concomitantly experienced both a primary hCMV-and EBV infection.
Similar to the memory populations, acute phase hCMV-specific cells highly expressed T-bet and much less so Eomes, whereas the reverse was true for the EBV-specific populations ( Figure 6A ). Furthermore, acute phase EBV-specific cells highly expressed granzyme K and only little granzyme B, where again the opposite went for hCMV-specific cells ( Figure 6A ). These trends continued until viral loads were undetectable and infections had entered the latency stage ( Figure 6A ).
Because these patients progressed from an EBV/hCMV seronegative status to a dually infected status, with a long-term follow-up period during viral latency, this provided us with the unique opportunity to see whether EBV/hCMV infection history indeed changes the associations between surface marker phenotype, T-bet/Eomes expression levels and expression of molecules predictive for function, also over time. In all surface markerdefined subsets, an increase in expression of T-bet, Eomes and granzyme B was evident ( Figure 6B) . Interestingly, the expression of IL-7Rα initially declined, only to slightly increase again long after the acute phase of infection ( Figure 6B ). The changes were less apparent for granzyme K and KLRG1 ( Figure 6B) .
Thus, the differential expression of T-bet, Eomes, granzyme K and granzyme B by these virus-specific CD8 + memory T-cell populations appears to be imprinted early during the acute phase of primary infection. Furthermore, also long after resolution of the primary infection, changes in the associations between different dimensions that define the differentiation state of CD8 + T-cells appear to occur.
DISCUSSION
In the current study we show that specific T-bet and Eomes expression states relate to Characteristics of EBV EBNA-and BZLF-1-specific (light-green and dark-green lines, respectively) and hCMV pp65-specific CD8+ T cells (blue line) circulating in two kidney transplant recipients (left and right columns) who were both EBV and hCMV seronegative prior to receiving kidney allografts from EBV-and hCMV-seropositive donors, followed over the course of a primary EBV and hCMV infection (EBV and hCMV viral loads as determined by qPCR indicated by the light-green and light-blue filled areas, respectively): absolute numbers of tetramer+ events (first row), Ki-67+ tetramer+ events (second row), T-bet GMFI (third row), Eomes GMFI (fourth row), granzyme B+ tetramer+ events (fifth row), and granzyme K+ tetramer+ events (last row). Graphs showing the expression of T-bet (first plot), Eomes (second plot), IL-7Rα (third plot), granzyme K (fourth plot), KLRG1 (fifth plot), and granzyme B (last plot) per CD45RA/CD27-defined subset (lines) over the course of transplantation and EBV/hCMV seroconversion.
T-cells from elite controllers generally display a higher expression of T-bet and cytotoxic
effector molecules like perforin and granzyme B when compared to chronically infected progressors and highly active antiretroviral therapy-suppressed individuals, arguing also for a strong effect of an individual's immunological make-up on the phenotype of virusspecific CD8 + T-cells 40 .
Because the frequency of virus-specific CD8 + T-cells targeting a single virus in the total CD8 + T-cell pool is low, we expect that the changing associations between T-cell function, surface marker expression and T-bet/Eomes expression levels, according to infection history, may be regulated on several levels other than simply the presence of virusspecific populations. For example, human CMV, EBV and HIV-1 have been shown to utilize strategies aimed at disrupting T-cell activation on various levels that are like to impact the overall make-up of the CD8 + T-cell pool as well [41] [42] [43] [44] . Finally, in the context of viral coinfection, heterologous immunity, the process by which a T-cell originally raised against for example EBV is also able to react to presented hCMV epitopes, although probably with a different affinity/avidity, could also impact our findings. However, it is very difficult to hypothesize on the frequencies by which such events would occur. Nevertheless, if 
MATERIALS AND METHODS
Study subjects
PBMCs were obtained from buffy coats of 29 healthy blood donors aged in between 18 and 64 years ( Table I and II) . PBMC samples from 13 HIV-1-infected participants of the Amsterdam Cohort studies on the natural history of HIV-1 infection were selected on being HLA-B8 positive (Table III) . These patients were positive for HIV-1 antibodies at entry into the cohort between October 1984 and April 1985. In previous epidemiological studies, the time since seroconversion of these prevalent cases has been estimated based on the incidence of HIV-1 infection amongst homosexual participants of the Amsterdam Cohort and was on average 1.5 years before entry into the cohort studies 49 . None of these patients had received antiretroviral therapy at analysis (Table III) . Cord blood samples were collected as rest material. PBMCs from two initially hCMV-and EBV seronegative kidney transplant recipients were longitudinally obtained (Table IV) .
Ethics statement
Inclusion of patients has been conducted in accordance with the ethical principles set out in the declaration of Helsinki. Both patient inclusion and blood sample collection were done with approval of the Amsterdam Medical Center Medical Ethical Committee. Written informed consent was obtained prior to data collection. Table III .
HIV-infected individuals
Gender Age Sample moment 
Isolation of PBMCs
PBMCs were isolated using standard density gradient centrifugation after which they were cryopreserved until the day of analysis.
Tetrameric complexes
All tetrameric complexes were obtained from Sanquin, Amsterdam, the Netherlands. See Table V for a list of all tetrameric complexes used.
Tetramer staining and phenotyping of CD8 + T-cells
PBMCs were incubated with the APC-labelled tetrameric complex (see Table V 
Gating strategy
Lymphocytes were gated using forward/sideward scatter properties ( Figure S1b ). Duplets were excluded using forward scatter width/height-and sideward scatter (SSC) width/ height characteristics ( Figure S1b ). Dead cells were excluded using Live/Dead fixable red cell fluorescence intensity (FI) ( Figure S1b ). CD3 + CD8 + (tetramer + ) events were gated as shown in Figure S1b . CD8 + T-cell subsets were gated first as CD45RA + CD27 + , CD45RA -CD27 + , CD45RA -CD27 -and CD45RA + CD27¯ populations ( Figure S1b ). CCR7-, CD27-and CD28-positive and negative events where then gated and dragged into the CD45RA/ CD27 populations, ultimately yielding 16 different gates that held events with a distinct CD45RA, CD27, CCR7, CD28 expression profile (Figure 1a) . T-bet and Eomes populations were gated as shown in Figure S1a using the SSC plotted against T-bet, the SSC plotted against Eomes and T-bet plotted against Eomes to determine the final gating.
IL-7Rα-, granzyme K-, KLRG1-and/or granzyme B gates, identifying positive or negative events, were then inserted in the CD45RA/CD27/CCR7/CD28 gates and/or in the T-bet/ Eomes gates.
Virological analyses
Quantitative polymerase chain reaction measurements to determine viral loads and serological assays to determine the presence of antiviral antibodies were done as described previously 51, 52 .
Statistical analyses
Differences in age between study groups were calculated using the Mann-Whitney test in groups to one another. Here we analyzed all four groups at once in order find out whether they were similar or not. Statistical differences between the absolute numbers of overalland naïve CD8 + T-cells (Figure 1e) , and the expression of IL-7Rα, granzyme K, KLRG1 and granzyme B by hCMV pp65-specific CD8 + T-cells in healthy and HIV-1-infected individuals (Figure 3c ), were assessed with unpaired student's t tests. Statistical differences between the expression of IL-7Rα, granzyme K, KLRG1 and granzyme B by the surface markerdefined-, or T-bet/Eomes expression level-defined subsets from groups of healthy adults with different EBV/hCMV infection histories were determined using one-way ANOVA tests ( Figure 5D , S7 and S8). Results were considered statistically significant when p values were lower than 0.05. Figure S9 . Infection history influences the associations between surface phenotype, T-bet/Eomes expression levels and the functional potential. Heat maps indicating the degree of expression of IL-7Rα (first column), granzyme K (second column), KLRG1 (third column) and granzyme B (last column) per combined surface marker-and T-bet/Eomes-defined CD8 + T-cell subset plotted on the X-and Y-axes, respectively, in cord blood samples (n=5, first row), EBV/hCMV seronegative individuals (n=6, second row), EBV mono-infected individuals (n=5, third row), hCMV mono-infected individuals (n=3, fourth row), EBV/hCMV double-infected individuals (n=6, fifth row) and HIV-1-infected individuals (n=13, last row). The degree of expression intensity is indicated by increments in color intensity and by the mean percentage of positive cells denoted in the boxes. Ns = not significant, * p<0.05, *** P<0.001.
